Immune checkpoint inhibitor-related thyroid dysfunction
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline;Brahmer;J Clin Oncol,2018
2. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for Immunotherapy of Cancer (SITC) toxicity management working group;Puzanov;J Immunother Cancer,2017
3. Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society;Arima;Endocri J,2019
4. Society for Endocrinology Clinical C. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: acute management of the endocrine complications of checkpoint inhibitor therapy;Higham;Endocr Connect,2018
5. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system;Zhai;J Immunother Cancer,2019
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression;Acta Pharmaceutica Sinica B;2024-09
2. Concurrent Gitelman Syndrome and Hyperthyroidism: Diagnostic Challenges in a 51-Year-Old Patient;American Journal of Case Reports;2024-07-25
3. Causes of difficulties with adequate levothyroxine substitution — an immunoendocrine perspective;Endokrynologia Polska;2024-07-24
4. Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy;Endocrine Practice;2024-07
5. Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study;Cancer Immunology, Immunotherapy;2024-06-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3